- About us
- UCD Clinical Trials
- Myeloma Ireland 2013
Prof J Laubach, expert in multiple myeloma, will dicuss recent advances in Multiple Myeloma management. More information on Prof Laubach and Dana Farber can be found here.Dr. Peter O'Gorman , Mater University Hospital, Dublin, Ireland
Dr. O'Gorman founder of MIRT and Consultant Haematologist will speak on the latest updates in clinical trials in Ireland and the impact they have on the patient. More information on Dr. O'Gorman and MIRT can be found here.Mary Kelly Advanced Nurse Practitioner in Haematology for Dublin & Mid Leinster Region, Ireland
Ms Kelly set up Ireland's first myeloma support group, running monthly meetings to provide advice and support to patients, families and carers.
Mr Gerry Keenan – Ardfarna, Bundoran, Co Donegal
In October 2012, Gerry went for his regular 6-monthly blood tests for his diabetes. Much to his surprise, he was sent to Sligo General Hospital for further test. It took a number of tests to establish that he had Multiple Myeloma.
“I never heard of Multiple Myeloma before and I was totally surprised to be diagnosed with it, as I had not been feeling sick and indeed I was working the day I went to the hospital,” said Gerry, who works in the construction industry.
Once the diagnosis was made Gerry was transferred to Galway University Hospital, under the care of Prof Michael O’Dwyer. After chemotherapy last May, his stem cells were harvested and transplanted back into his system.
“The harvesting and transplant went well and I felt grand. They told me that my system would be at a low for a while and as I felt so well I did not believe them. Then, when it went down, I was very sick. I could not even swallow water. It took a while for me to recover, but I am back at home now.”
The nursing staff, who are now part of Multiple Myeloma Ireland, provided Gerry with information and assistance during his treatment. “I am very grateful to the doctors and the nursing staff for all their help and advice. It is very important that you understand what is happening and know the treatment you are receiving
Gerry has had one further chemotherapy session and he is due a final one at the end of November. “At my last visit, Prof O’Dwyer said that I was doing very well. He explained that usually there are traces of the myeloma still in the blood system after the transplant. But in my case the blood was clear.”
As a result of this, Prof O’Dwyer shared the results with his colleague, Dr. Paul Richards from Dana-Farber Cancer Institute in Boston and a clinicial plan was agreed for Gerry. “I am due back to Prof O’Dwyer in December and I hope that we still have it under control,” he said.
Prof O’Dwyer and his colleagues are members of the all-Ireland cooperative oncology research group that work closely with Dana-Farber Cancer Institute in Boston, USA, on research and development of treatment, including clinical trials of new drugs, for a range of blood cancers including multiple myeloma.
Prof O’Dwyer will be speaking during the Multiple Myeloma Ireland Event on Thursday 14th Novermber. For more information please check www.mirtireland.com/myeloma-ireland